UnitedHealth’s stock can soar 40% as antitrust concerns are overblown, BofA says

by admin 0 Comments

Daily Trade
Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn

[unable to retrieve full-text content]

This article was originally published by Marketwatch.com. Read the original article here.
Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn

Articles You May Like

Acurx Pharmaceuticals to add up to $1 million in bitcoin for treasury reserve, following MicroStrategy’s playbook
Autonomous Vehicles: Why 2025 Will Usher in the Self-Driving Car
Processed food stocks fall as investors brace for increased scrutiny under Trump, RFK Jr.
‘I’m 38 and completely broke’: I earn $50,000 a year. What professional degree will guarantee me six figures?
Top Wall Street analysts are upbeat on these stocks for the long haul